- Trials with a EudraCT protocol (134)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
134 result(s) found for: Contrast sensitivity.
Displaying page 1 of 7.
EudraCT Number: 2007-004746-33 | Sponsor Protocol Number: 310123 | Start Date*: 2008-09-17 | |||||||||||
Sponsor Name:Bayer HealthCare Pharmaceuticals INC | |||||||||||||
Full Title: A multicenter, randomized, double-blind, crossover, phase 3 study to determine the safety and efficacy of gadobutrol 1.0 molar (Gadovist®) in patients referred for contrast-enhanced MRI of the cent... | |||||||||||||
Medical condition: Male and female patients of any ethnic group who are referred for a contrast-enhanced MRI of the CNS based on current clinical symptoms or results of a previous imaging procedure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002053-31 | Sponsor Protocol Number: ALEC4005 | Start Date*: 2005-08-16 |
Sponsor Name:Hammersmith Hospital | ||
Full Title: To determine the diagnostic accuracy of MRI in detecting lymph node metastases using USPIO (Ultra small super-paramagnetic iron oxide particles) in patients with gynecological malignancy | ||
Medical condition: Gynaecological malignancies | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2020-000993-27 | Sponsor Protocol Number: 2019PI115 | Start Date*: 2020-07-16 | |||||||||||
Sponsor Name:CHRU NANCY | |||||||||||||
Full Title: AGATA: Value of contrast-enhanced ultrasound in adnexal torsion | |||||||||||||
Medical condition: Adnexal torsion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000174-25 | Sponsor Protocol Number: 101090401IN | Start Date*: 2023-03-17 | |||||||||||
Sponsor Name:SANTEN INCORPORATED | |||||||||||||
Full Title: A Phase IIa, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared with Vehi... | |||||||||||||
Medical condition: Fuchs Endothelial Corneal Dystrophy (FECD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000940-17 | Sponsor Protocol Number: 64Cu | Start Date*: 2018-05-07 |
Sponsor Name: | ||
Full Title: Phase IIa clinical study of 64 CuCl2: efficacy and safety of a new tracer for urologic tumors | ||
Medical condition: Genitourinary tract tumors in male patients | ||
Disease: | ||
Population Age: Elderly | Gender: Male | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001619-37 | Sponsor Protocol Number: 48895 | Start Date*: 2014-07-14 |
Sponsor Name:Maastricht University Medical Centre | ||
Full Title: Contrast enhanced Diffusion-weighted Magnetic Resonance Imaging for detection of pathologic lymph nodes in ovarian cancer – a feasibility study. | ||
Medical condition: Ovarian Cancer - diagnosis of lymph nodes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001296-67 | Sponsor Protocol Number: CBFU | Start Date*: 2016-07-26 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE TUMORI - IRCCS FONDAZIONE PASCALE | |||||||||||||
Full Title: DUAL ENERGY CONTRAST ENHANCED DIGITAL MAMMOGRAPHY PERFORMANCE EVALUATION IN COMPARISON OF CONVENTIONAL DIGITAL MAMMOGRAPHY, TOMOSINTESIS AND MR IMAGING IN WOMEN FOLLOW-UP FOR BREAST CARCINOMA | |||||||||||||
Medical condition: WOMAN WITH BREAST CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000819-67 | Sponsor Protocol Number: MTW_2020_KC01 | Start Date*: 2020-07-28 |
Sponsor Name:Maidstone and Tunbridge Wells NHS Trust | ||
Full Title: SENTINUS: Technical feasibility and diagnostic accuracy of intradermal microbubbles and contrast enhanced ultrasound to identify sentinel lymph node metastases in breast cancer patients following t... | ||
Medical condition: Breast Cancer - Using SonoVue injected intradermally into the breast and contrast enhanced ultrasound to see if the cancer has spread via lymphatic channels to sentinel lymph nodes in the axilla. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002288-29 | Sponsor Protocol Number: IEOS626/311 | Start Date*: 2012-03-29 | |||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||
Full Title: New frontiers in breast imaging: contrast enhanced digital mammography. - Clinical performance of contrast-enhanced spectral mammography (CESM - SenoBright) in pre-surgical evaluation of extent o... | |||||||||||||
Medical condition: Breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023001-36 | Sponsor Protocol Number: BAY86-4875/14607 | Start Date*: 2011-04-26 | |||||||||||
Sponsor Name:Bayer Health Care AG | |||||||||||||
Full Title: Multicenter, open-label study to evaluate the safety and efficacy (by blinded reading) of contrast-enhanced magnetic resonance angiography (MRA) after a single intravenous injection of 0.1 mmol/k... | |||||||||||||
Medical condition: Subjects with known or suspected vascular disease of the supra-aortic vessels | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) SE (Completed) FR (Completed) IT (Completed) PL (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001874-32 | Sponsor Protocol Number: RDC-CNGA3-01 | Start Date*: 2015-09-09 | |||||||||||
Sponsor Name:Universitätsklinikum Tübingen | |||||||||||||
Full Title: Safety and efficacy of a bilateral single subretinal injection of rAAV.hCNGA3 in adult and minor patients with CNGA3-linked achromatopsia investigated in a randomized, wait list controlled, observe... | |||||||||||||
Medical condition: CNGA3-linked achromatopsia | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000827-11 | Sponsor Protocol Number: T50/2021 | Start Date*: 2022-09-02 |
Sponsor Name:Turku University Hospital | ||
Full Title: Clinical use of USPIO contrast media in the assessment of pelvic lymph node metastasis in rectal cancer. | ||
Medical condition: Pelvic lymph node metastasis in rectal cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001386-42 | Sponsor Protocol Number: REC no:06/Q0403/25 | Start Date*: 2006-07-06 |
Sponsor Name:Imperial College | ||
Full Title: The timing of intra-vitreal (4mg) triamcinolone acetonide, in addition to verteporfin photodynamic therapy for choroidal neovascularisation, in age-related macular degeneration: a prospective rando... | ||
Medical condition: Submacular choroidal neovascularisation in Age-related Macular Degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002588-32 | Sponsor Protocol Number: 7TNANO2 | Start Date*: 2016-09-15 |
Sponsor Name:Radboudumc | ||
Full Title: USPIO- enhanced High Field MRI for restaging lymph node status in rectal cancer: an explorative study | ||
Medical condition: Lymph node metastases in rectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022791-31 | Sponsor Protocol Number: D01092010AZNTG | Start Date*: Information not available in EudraCT | |||||||||||||||||||||||||||||||
Sponsor Name:University Erlangen-Nuremberg | |||||||||||||||||||||||||||||||||
Full Title: Contrast sensitivity of patients with normal tension glaucoma by application of Azarga® | |||||||||||||||||||||||||||||||||
Medical condition: The effect of AZARGA(R) on the central and spacial-temporal contrast sensitivity of patients with normal tension glaucoma will be examined. Healthy controls are required to prove the disease specif... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004613-18 | Sponsor Protocol Number: MH-131 | Start Date*: 2007-06-04 | |||||||||||
Sponsor Name:BRACCO IMAGING | |||||||||||||
Full Title: Phase III, Multicenter, Double-blind, Randomized, Crossover Study to Compare MultiHancE with MagnevisT in Contrast-Enhanced MagnetiC Resonance Imaging MRI of the BreasT. - DETECT - | |||||||||||||
Medical condition: patiens with breast lesions which are highly suspicious or already known for malignancy which are requested for MRI | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) DE (Completed) GB (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000089-12 | Sponsor Protocol Number: HIP/FUSION#4 | Start Date*: 2018-04-24 | |||||||||||
Sponsor Name:Institut for Klinisk Medicin, Aarhus Universitet | |||||||||||||
Full Title: Effect and safety of the iliopsoas plane block in healthy volunteers | |||||||||||||
Medical condition: No specific medical condition is investigated. The objective of the trial is to investigate a method for postoperative analgesia after elective hip surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002274-22 | Sponsor Protocol Number: MH-127 | Start Date*: 2006-12-18 | |||||||||||
Sponsor Name:Bracco Imaging S.p.A. | |||||||||||||
Full Title: A PHASE IIIB, DOUBLE-BLIND, MULTI-CENTER, RANDOMIZED, CROSS-OVER STUDY TO COMPARE 0.1 MMOL/KG OF MULTIHANCE® WITH 0.1 MMOL/KG OF MAGNEVIST® FOR CONTRAST-ENHANCED MAGNETIC RESONANCE ANGIOGRAPHY (CE-... | |||||||||||||
Medical condition: Subjects with moderate-to-severe peripheral arterial disease based on the Fontaine’s staging of peripheral arterial occlusive disease classes IIb, III and IV | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001914-34 | Sponsor Protocol Number: 01052006 | Start Date*: 2006-08-30 |
Sponsor Name:Bert Mueller, Dep. Ophthalmology | ||
Full Title: Treatment of neovascular age related macular degeneration with intravitreal Bevacizumab (Avastin) | ||
Medical condition: neovascular age-related macular degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004397-99 | Sponsor Protocol Number: MBCC28040 | Start Date*: 2014-06-17 |
Sponsor Name:Instituto Tecnológico PET, S.A.U. (ITP) | ||
Full Title: A Phase III Clinical Trial to evidence the safety and efficacy of the radio-drug 18f-Fluorocholine (18F-FCH), using Positron Emission Tomography (PET) for the diagnosis of the prostate carcinoma in... | ||
Medical condition: Prostate Carcinoma in patients with biochemical relapse. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
